High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program—A Prospective Nationwide, Population-Based Study

BACKGROUND: The Treatment as Prevention for Hepatitis C program started in 2016 in Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected individuals. Reinfections through injection drug use (IDU) can hamper elimination efforts. We determined reinfection rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Johannesson, Jon M, Fridriksdottir, Ragnheidur H, Löve, Thorvardur J, Runarsdottir, Valgerdur, Hansdóttir, Ingunn, Löve, Arthur, Thordardottir, Marianna, Hernandez, Ubaldo B, Olafsson, Sigurdur, Gottfredsson, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662175/
https://www.ncbi.nlm.nih.gov/pubmed/35438144
http://dx.doi.org/10.1093/cid/ciac272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662175/
https://www.ncbi.nlm.nih.gov/pubmed/35438144
http://dx.doi.org/10.1093/cid/ciac272

Ejemplares similares